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The FimH adhesin of Escherichia coli type 1 fimbriae confers the ability to bind to D-mannosides by virtue
of a receptor-binding domain located in its N-terminal region. This protein was engineered into a heterobi-
functional adhesin by introducing a secondary binding site in the C-terminal region. The insertion of histidine
clusters into this site resulted in coordination of various metal ions by recombinant cells expressing chimeric
FimH proteins. In addition, libraries consisting of random peptide sequences inserted into the FimH display
system and screened by a “panning” technique were used to identify specific sequences conferring the ability
to adhere to Ni21 and Cu21. Recombinant cells expressing heterobifunctional FimH adhesins could adhere
simultaneously to both metals and saccharides. Finally, combining the metal-binding modifications with al-
terations in the natural receptor-binding region demonstrated the ability to independently modulate the
binding of FimH to two ligands simultaneously.
Expression systems for the display of heterologous protein
segments facilitate the presentation of both defined and ran-
dom peptide sequences at exposed regions of surface proteins
of filamentous bacteriophage virions, bacteria, and yeasts (2,
4). We are particularly interested in the display of heterolo-
gous peptides in type 1 fimbriae. Such surface organelles are
found on the majority of Escherichia coli strains and confer the
ability to bind to specific surfaces. A single type 1 fimbria is a
heteropolymer that is 7 nm wide and approximately 1 mm long.
It consists of approximately 1,000 subunits of the major ele-
ment, FimA, that are polymerized in a right-handed helical
structure that also contains low levels of the minor components
FimF, FimG, and FimH (9). The FimH protein has been
shown to be the actual receptor-binding molecule which
recognizes a-D-mannose-containing structures (10). Because
of this, type 1 fimbriated bacteria readily agglutinate yeast cells
(a rich source of mannan).
The FimH adhesin is located at the tip of each fimbria and
also is interspersed along the fimbrial shaft (6, 10). The results
of linker insertion mutagenesis (16) and analyses of naturally
occurring variants (17–19) and hybrid proteins constructed by
fusing FimH to FocH (8) and MalE (21) suggest that the FimH
protein consists of two major domains, each constituting rough-
ly one-half of the molecule; the N-terminal domain seems to
contain the receptor-binding site, while the C-terminal domain
seems to contain the recognition sequences for export and
bioassembly.
In previous studies we investigated the ability of FimH to
display heterologous peptides in connection with the develop-
ment of vaccine systems. Various heterologous sequences, rep-
resenting immune-relevant sectors of foreign proteins, were
authentically displayed on the bacterial surface in FimH (12).
These observations led us to believe that the FimH protein is
an ideal candidate for display of random peptide sequences
and for construction of designer adhesins (i.e., proteins ma-
nipulated to bind to targets of choice). Here we describe si-
multaneous heterobifunctional binding of recombinant cells
expressing chimeric FimH proteins to metal and D-mannose
targets.
MATERIALS AND METHODS
Strains and plasmids. E. coli S1918 (F2 lacIq DmalB101 endA hsdR17 supE44
thi1 relA1 gyrA96 DfimB-H::kan) (3) was used in this study. Strains were grown in
Luria-Bertani medium supplemented with the appropriate antibiotics (14). The
FimH expression vector pLPA30 is a pUC18 derivative containing the fimH gene
downstream of the lac promoter and has a BglII linker inserted at position 225
(12). Plasmid pPKL115 is a pACYC184 derivative containing the whole fim gene
cluster with a stop linker inserted into the fimH gene (12). Plasmid pMAS25 was
made by inserting an 18-bp synthetic double-stranded DNA segment encoding
six consecutive histidine residues and containing a BglII overhang at one end and
a BamHI overhang at the other end into the BglII site of pLPA30. The double-
stranded polyhistidine segment resulted from the annealing of two oligonucleo-
tides (59-GATCTCATCACCATCATCACCATG and 59-GATCCATGGTGAT
GATGGTGATGA). Plasmid pNSU36 was made by digesting pMAS25 with BglII
and inserting a second polyhistidine DNA segment. Plasmid pMAS1 contained
the fimH gene from E. coli PC31 (7) inserted into pUC19. Plasmid pMAS37 was
made by performing overlapping PCR with a set of oligonucleotides which am-
plified the N-terminal half or fimH from E. coli CI#4 (19) and the C-terminal
half of fimH from pNSU36 and then ligating the product into pUC19. Each PCR
was performed as previously described (12) with the Expand High Fidelity PCR
system (Boehringer, Mannheim, Germany). DNA sequencing was carried out by
the dideoxy chain termination technique (15) with a Sequenase version 2.0 kit
(U.S. Biochemicals).
Construction of the random library. The random library was constructed es-
sentially as described by Brown (3). Briefly, a template oligonucleotide contain-
ing the sequence 59-GGACGCAGATCT(VNN)9AGATCTAGCACCAGT-39
was chemically synthesized (N indicates an equimolar mixture of all four nucleo-
tides, and V indicates an equimolar mixture of A, C, and G). A primer oligo-
nucleotide, 59-ACTGGTGCTAGATCT-39, was hybridized to the template oli-
gonucleotide and extended with the Klenow fragment of DNA polymerase I.
The double-stranded oligonucleotide was extracted twice with phenol-chloro-
form and ethanol precipitated. Digestion with BglII released an internal 33-bp
fragment which was purified by electrophoresis through a 12% polyacrylamide
gel in TBE. The 33-bp fragment was excised and eluted from the gel with a buffer
containing 10 mM Tris-HCl (pH 8.0), 2 mM EDTA, and 0.15 M NaCl. The
eluate was filtered through a 0.22-mm-pore-size Qiagen filter, concentrated by
ethanol precipitation, and redissolved in 10 mM Tris-HCl (pH 8.0)–1 mM
EDTA–0.1 M NaCl. The redissolved 33-bp BglII fragment was ligated at various
ratios to BglII-digested pLPA30. The ligation products were precipitated with
ethanol and electroporated into S1918 (containing pPKL115).
The diversity of the library was calculated to be 4 3 107 individual clones based
on extrapolation from numbers of transformants obtained in small-scale platings.
The volume of each transformation mixture was brought to 10 ml, and each
mixture was grown for approximately seven generations (4 3 109 cells). Aliquots
(1 ml) were frozen at 280°C in 25% glycerol. Each 1-ml aliquot contained
approximately 4 3 108 cells, which represented 10 times the library diversity.
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Random screening of clones by PCR revealed a predominance of one to three
33-bp oligonucleotide inserts; sequencing of the inserts from randomly selected
clones revealed G1C contents ranging from 30 to 70%.
Enrichment procedure. Bacterial cells were bound to nickel ions by use of a
commercially available Ni21-nitrilotriacetic acid (NTA) solid matrix (Qiagen).
The NTA ligand has four chelating sites which interact with each nickel ion. This
leaves two of the six ligand-binding sites in the coordination sphere of the Ni21
ion to interact with the histidine tag. The enrichment procedure used to identify
Ni21-binding clones from the random library was as follows. Mid-exponential-
phase cultures were diluted with M63 salts (11) containing 20 mM a-methyl-
mannopyranoside and 50% Percoll (Pharmacia). The a-methylmannopyranoside
was added to block the natural binding of the FimH adhesin, while the use of
Percoll resulted in the formation of a density gradient upon centrifugation. This
resulted in the formation of a distinct band by the Ni21-NTA resin and specific
separation of any adherent bacteria from nonadherent bacteria. Under these
conditions, bacteria expressing wild-type FimH proteins as components of type 1
fimbriae did not coseparate with the Ni21-NTA resin. The resin and bacteria
expressing the random library within FimH were mixed and allowed to adhere at
room temperature with gentle agitation. Centrifugation was then performed, and
the resin and any adhering bacteria were removed and plated onto L-agar
containing appropriate antibiotics. After overnight incubation colonies were
pooled from the surfaces of the plates, exponentially growing cultures were
established, and the enrichment procedure was repeated. Following each cycle of
enrichment aliquots of the populations were stored at 280°C. Plasmid DNA was
prepared from each aliquot and used in a PCR to monitor the size distribution
of the inserts in the population.
Binding assays. Mid-exponential-phase cultures were washed, resuspended in
M63 salts, and then mixed simultaneously with either Ni21-NTA agarose beads
(Qiagen) and Saccharomyces cerevisiae cells or a-D-methylmannopyranoside aga-
rose beads (Sigma) and NiO. Samples were incubated at room temperature for
15 min with gentle agitation prior to examination by phase-contrast microscopy.
When it was necessary to block the natural FimH binding site, a-D-methylman-
nopyranoside was used at a final concentration of 20 mM. The binding of cells to
the Ni21-NTA resin was reversed by using an imidazole gradient (1 to 50 mM)
(5). Binding of cells to casein and yeast mannan was performed in microtiter
plates as previously described (18), except that bound cells were eluted without
prior incubation.
Binding to metals. Metal oxides (NiO, CuO, ZnO, and CdO) were purchased
from Aldrich. Particles of the appropriate size for microscopy were prepared by
differential centrifugation. Metal oxides were suspended in M63 salts before
bacteria were added. Samples were incubated at room temperature for 15 min
with gentle agitation and examined microscopically. An alternative procedure to
demonstrate metal-binding capacity was to measure the bioaccumulation of
either Ni21 or Cd21 by recombinant bacteria by atomic adsorption. Late-expo-
nential-phase cultures were washed in M63 salts and resuspended in the same
medium containing 20 mM NiCl2 or CdCl2. The cells were incubated for 30 min
to allow adsorption of the metal ions and washed twice in M63 salts. Samples
were prepared and analyzed with a Perkin-Elmer model 2100 atomic adsorption
spectrophotometer as previously described (13).
RESULTS
Construction of a FimH-polyhistidine hybrid protein. We
previously identified two positions in the C-terminal domain of
the FimH protein which can tolerate the insertion of heterol-
ogous sequences (12). In this study, we used the FimH expres-
sion vector pLPA30, which contains the fimH gene with an in-
frame BglII linker inserted at a position encoding amino acid
residue 225 and placed under transcriptional control of the lac
promoter. In order to express chimeric FimH molecules as
functional constituents of fimbriae, we also used an auxiliary
plasmid (pPKL115) encoding the rest of the fim gene cluster
(Fig. 1).
A synthetic DNA segment encoding six tandem histidine res-
idues was constructed by annealing two complementary 24-bp
oligonucleotides designed to create a final double-stranded
DNA segment with a BglII overhang at one end and a BamHI
overhang at the other end. This feature permitted the intro-
duction of one and two such segments into plasmid pLPA30,
resulting in plasmids pMAS25 and pNSU36, respectively. Se-
quence analysis confirmed the insert orientation and conserva-
tion of the reading frame in the chimeric fimH genes. Receptor
blots of the two chimeric FimH proteins with a-D-mannosy-
lated bovine serum albumin indicated that these molecules
were synthesized as full-length products. The presence of bio-
logically active chimeric FimH proteins on the surface of re-
combinant cells was demonstrated by the ability of the cells to
cause strong agglutination of yeast cells.
Heterobifunctionality of the FimH adhesin. To demonstrate
that simultaneous heterobifunctional binding of the engineered
FimH protein occurred, we presented the recombinants with
targets for both the natural receptor site and the C-terminal
polyhistidine insert at the same time (Fig. 2). We observed bind-
ing in both directions (i.e., binding to the metal resin followed
by the D-mannose target [yeast] or binding to D-mannose beads
followed by NiO). Binding to the Ni21-NTA resin was found
to be dependent on the introduced polyhistidine clusters as a
strain carrying the wild-type fimH gene did not adhere to the
resin. In addition, binding to the Ni21-NTA resin could be
reversed by adding imidazole. The adherence of yeast cells to
bacteria bound to the Ni21-NTA resin could also be blocked by
adding methyl-a-D-mannopyranoside (Fig. 2). Taken together,
these results demonstrate that two independent adhesive do-
mains on the FimH protein can be used to bind cells to dif-
ferent target molecules simultaneously.
Modification of the natural receptor-binding site of FimH.
The fimH gene used as a basis for manipulations was originally
cloned from the E. coli K-12 strain PC31. The corresponding
FimH molecule confers the ability to bind to a-D-mannosides
but not to other targets, such as proteins. However, certain
wild-type versions of FimH confer the ability to bind to protein
targets and display higher affinity for a-D-mannosides due to
minor changes in the N-terminal receptor recognition domain
(17–19). In order to demonstrate the ability to manipulate the
natural binding site of the FimH adhesin, we exchanged this
domain with that of the naturally occurring wild-type variant
CI#4 (19). We used overlapping PCR to construct a hybrid
fimH gene in which the first half originated from CI#4 and
the second half originated from pNSU36. The FimH adhesin
FIG. 1. Plasmids used in this study. Only relevant nonvector sectors are
shown. (A) fim gene cluster present in pPKL115. The triangle indicates the po-
sition of the translational stop linker in the fimH gene. (B) fimH expression
vector pLPA30 together with the insert sequences of plasmids identified in this
study which conferred the ability to adhere to metals on recombinant cells.
Plasmids pMAS38 to pMAS47 and plasmids pMAS48 to pMAS51 were isolated
after four and five enrichments, respectively.
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from CI#4 has previously been shown to bind to protein tar-
gets, such as casein, and to possess enhanced affinity for man-
nan (19). The new hybrid FimH protein was shown to have the
same binding phenotype for both casein and mannan (Fig. 3),
while at the same time it also retained its ability to bind to Ni21
ions. These results demonstrate that the natural binding do-
main in the N-terminal part of the FimH adhesin can be ma-
nipulated and that there is a change in receptor affinity. At the
same time a heterologous insert in the C-terminal part of the
same molecule confers the ability to bind to a secondary target
(viz., nickel).
Selection of Ni21-adhering bacteria from a random library.
Since we demonstrated that the FimH protein could be engi-
neered to confer metal-binding properties on a recombinant
cell, we were confident that the Ni21-NTA resin was a suitable
target to evaluate the use of the fimbrial system for displaying
random peptide sequences. A random library was constructed
by inserting various numbers of synthetic double-stranded oli-
gonucleotides into the BglII site at position 225 of the fimH
gene. The double-stranded oligonucleotides consisted of nine
random codons flanked by BglII restriction sites, encoding
arginine and serine. This genetic structure allowed us to con-
FIG. 2. Phase-contrast microscopy showing the heterobinary binding properties of cells expressing engineered FimH adhesins. S1918(pNSU36, pPKL115) was
mixed with Ni21-NTA agarose beads and yeast cells in the absence (A) or presence (B) of 20 mM a-D-methylmannopyranoside. S1918(pMAS1, pPKL115) (C) and
S1918 (pNSU36, pPKL115) (D) were mixed with a-D-methylmannopyranoside-coated agarose beads and NiO.
FIG. 3. Adhesion of cells expressing wild-type (pMAS1) (open bars) and
hybrid (pMAS37) (solid bars) FimH proteins to casein and yeast mannan. Values
are the mean numbers of bacteria bound per well 1 standard errors of the means
(n 5 4).
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struct libraries containing one or more double-stranded 33-bp
oligonucleotides, a feature which greatly enhanced the com-
plexity of the libraries. In addition, the distribution of the
population through the enrichment procedure could be mon-
itored by PCR amplification of the insert region with primers
complementary to the vector sequence flanking the insertion
site.
Serial selection and enrichment of the random library was
performed with the Ni21-NTA resin. PCR monitoring of the
insert population revealed a distinct change in the size distri-
bution after four cycles of selection and enrichment. In a con-
trol experiment, 10 cycles consisting of growth of the popula-
tion, washing in M63 salts in the absence of Ni21-NTA resin,
and regrowth did not alter the size distribution of the insert
sequences. Of 50 randomly selected colonies from the fourth
enrichment, 11 were shown to bind to the Ni21-NTA resin and
were examined further. The FimH-containing plasmids were
isolated from each strain, and the insert region was sequenced.
Ten different insert sequences were identified (Fig. 1). Inter-
estingly, the insert sequence encoded by plasmid pMAS38 was
identified in 2 of the 11 plasmids. This sequence contained a
unique ScaI restriction site which could be used to monitor the
prevalence of the insert in the fifth enrichment. Eight of 12
clones identified as binding to Ni21 from the fifth enrichment
contained this unique restriction site, indicating that this insert
was the dominant sequence enriched throughout the selection
procedure. The remaining four inserts were also examined and
contained sequences which differed from those identified in
the previous enrichment (Fig. 1). All of the insert sequences
contained histidine residues, providing further evidence that
this amino acid plays a role in the binding of proteins to Ni21.
Binding of selected clones to metal oxides. The 14 different
plasmids identified from the random library which conferred
affinity to Ni21 were purified and retransformed into S1918
(pPKL115). The new recombinant clones had the same binding
phenotype as the original isolates, indicating that the binding
phenotype was indeed plasmid encoded. Although these clones
were originally selected in M63 salts containing 20 mM a-
methylmannopyranoside and 50% Percoll, they also had the
same binding phenotype in M63 salts alone, indicating that
these reagents had no effect on the stability of the metal-
binding capacity. The binding of these clones to the Ni21-NTA
resin could be inhibited by adding imidazole, as previously
observed with the clones harboring one and two histidine clus-
ters. The agglutination titers of these cells were similar to those
of a control strain expressing wild-type FimH, indicating that
FIG. 4. Phase-contrast microscopy showing the adherence of S1918 cells containing plasmids expressing various chimeric fimH genes to metal oxides. The plasmids
used were pLPA30 (wild-type fimH), pMAS25 (containing one polyhistidine insert), and pNSU36 (containing two polyhistidine inserts), as well as pMAS38 and
pMAS42 (random clones). Cells were incubated in M63 salts medium alone or in M63 salts medium containing NiO, CuO, or CdO.
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the presence of the inserts did not influence the natural bind-
ing domain of FimH or significantly alter the number of fim-
briae on the surfaces of the cells.
To investigate whether the plasmids isolated conferred
the ability to recognize other metals, transformants of S1918
(pPKL115) harboring these plasmids were examined in bind-
ing assays with NiO, CuO, and CdO by phase-contrast micros-
copy. All of the clones formed aggregates when they were
mixed with either NiO or CuO but not when they were mixed
with CdO. Figure 4 shows the binding of clones harboring
plasmids pMAS38 and pMAS42. Recombinant clones har-
boring pMAS25 and pNSU36 (containing one and two histi-
dine clusters, respectively) formed aggregates with all three
metal oxides. The different sizes of the cell-metal aggregates
indicated that there were differences in the avidities of the
various clones for each of the metals. In a separate assay to
monitor avidity for metal ions, atomic adsorption spectroscopy
was used to measure the amounts of Ni21 or Cd21 associated
with clones harboring either pMAS25, pNSU36, or pMAS38.
The amount of metal associated with these cells was signifi-
cantly different from the amount of metal associated with cells
expressing wild-type FimH-containing fimbriae (Fig. 5).
DISCUSSION
In this study we developed heterobifunctional adhesins
based on the FimH component of E. coli type 1 fimbriae. This
novel technology is based on the following rationale. Insertion
of heterologous sequences in the C-terminal part of FimH
does not disturb the natural receptor-binding domain located
in the other end of the FimH protein, which mediates targeting
to D-mannosides. Consequently, random peptide libraries can
be displayed in one sector of the molecule and can be selected
based on affinity to a given target. At the same time the natural
binding domain remains intact and, in the case of wild-type
affinity, confers the ability to bind to D-mannosides. This per-
mits immobilization of bacteria on a matrix containing one
type of receptor, while at the same time the secondary binding
site is available for interaction with its cognate target.
The heterobifunctionality of engineered FimH adhesins was
demonstrated by using two different binding targets. Cells ex-
pressing these proteins as fimbrial components were able to
adhere to both metal and D-mannose targets simultaneously.
Insertion of polyhistidine clusters into FimH resulted in re-
combinant cells that were able to form aggregates with NiO,
CuO, and CdO, as well as ZnO (data not shown). It has been
reported previously that histidine residues inserted into the
LamB protein conferred the ability to bind to Ni21 and Cd21
on recombinant cells (20). Our results are consistent with these
findings and support the observation that increased binding
avidity occurs when there are tandem inserts. However, the
attractions of the present display system are the availability of
two functionally distinct binding domains in the same protein
and the ability to manipulate these domains independently.
The random peptide display technology allows large popu-
lations of diverse peptides to be screened for specific bind-
ing affinity to an immobilized target. A number of peptide
sequences conferring the ability to coordinate Ni21 ions were
selected from the random library constructed in the FimH
fimbrial protein. A common feature found in all of the se-
quences was the presence of at least one histidine residue.
Histidine has previously been shown to participate in the co-
ordination of various metals (Ni21, Cu21, Zn21) by proteins
(1). The insert present in the most enriched clone (pMAS38) is
interesting since it contains only one histidine residue but is
rich in proline residues. Taking into account the VNN coding
scheme which we used in the genetic structure of our library,
we also observed enrichment for arginine residues. Interest-
ingly, both proline and arginine provide a nitrogen-located
electron lone pair which perhaps could be involved in che-
lating metal ions. No similarities to other nickel-binding
sequences in the database were identified. It is apparent that
this display system provides a plethora of structural solutions
to metal binding. Analysis of all of the clones indicated that in
some cases only one histidine residue in the insert sequence is
required to confer the ability to bind to metal ions on recom-
binant cells expressing the chimeric FimH proteins. It is pos-
sible that the folding of the chimeric FimH proteins is such that
naturally occurring histidines in the protein (of which there are
two) also participate in the construction of the Ni21-binding
site. Alternatively, the fimbrial structure may be such that more
than one FimH molecule is able to participate in metal ion
chelation. This may be particularly significant in light of the ob-
servations of Jones et al. (6), who observed tip fibrillar com-
plexes at the distal ends of type 1 pilus rods, suggesting that
multiple copies of FimH are present. The correct interpreta-
tion of these observations awaits resolution of the FimH three-
dimensional structure by X-ray crystallography.
The N-terminal part of the FimH protein contains a natural
receptor-binding domain which recognizes D-mannoside-con-
taining structures. Molecular exchange techniques were used
to demonstrate that this domain can be manipulated to confer
the ability to bind to protein targets. We envisage the possi-
bility that an interesting range of heterobinary adhesins can be
constructed by combining the two types of technology (i.e., an
FIG. 5. Results of atomic adsorption spectroscopy performed to determine
the amount of Ni21 (A) or Cd21 (B) associated with cells containing plasmid
pLPA30 (wild-type fimH), pMAS38 (random clone), pMAS25 (containing one
polyhistidine insert), or pNSU36 (containing two polyhistidine inserts). Data
from a single experiment are shown; however, the experiment was repeated
several times, and the results of all experiments were essentially the same.
1632 SCHEMBRI AND KLEMM APPL. ENVIRON. MICROBIOL.
 o
n
 N
ovem
ber 10, 2015 by University of Queensland Library
http://aem
.asm
.org/
D
ow
nloaded from
 
altered natural binding site in the N-terminal end of this mol-
ecule combined with the ability to display peptides with bind-
ing affinity at the C terminus).
There are obvious advantages inherent in using the FimH
display system for the construction of heterobinary adhesins.
Two functionally distinct binding domains can be engineered
into one (binary) adhesin and presented on the bacterial sur-
face, which permits easy clone selection by selective binding
and enrichment procedures. In addition, immobilization of the
resulting cells by one adhesive domain could facilitate the use
of the cells in detection systems for metals or perhaps direct-
ly as biosorption agents for the removal of toxic or precious
metals from the environment. It is also possible to purify fim-
briae by blending if the chimeric proteins are used without
bacteria. Furthermore, there is also the potential to use the maj-
or fimbrial structural protein, FimA, to present binding se-
quences in high-valency display formats. Such technology may
have a role in the construction of ordered nanostructures.
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